Business Paid
OncoArendi Therapeutics records net loss of PLN 4.45 mln in 2018
21:00
WSE-listed biotechnology company OncoArendi Therapeutics recorded PLN 4.45 million of consolidated net loss in 2018 as compared to PLN 2.4 million a year earlier, the company…
This article is for subscribers
Warsaw Business Journal subscribers get the full archive (12,248 articles going back to 1995) and the print edition.
SubscribeOr try Poland A.M. free for 7 days, the daily briefing, or see all plans and prices.
